Project Grant HT9425261E237
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $810,171 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, with an ultimate completion date of August 31, 2028. The award supports research investigating the therapeutic effects of peroxisome proliferator-activated receptor alpha agonist on combat-induced proliferative vitreoretinopathy, a condition...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $621,779 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026 through March 31, 2029. The award supports research titled "Modulating Immune Stress Pathways as a Strategy for CIPN Prevention and Cancer Management," which addresses chemotherapy-induced peripheral neuropathy (CIPN) prevention while advancing cancer...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $627,944 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026, through March 31, 2029. The award supports research focused on modulating immune stress pathways as a strategy for chemotherapy-induced peripheral neuropathy (CIPN) prevention and cancer management. This three-year initiative leverages the institution's...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.8M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2028. The award funds research to develop PEDF (Pigment Epithelium-Derived Factor)-enriched exosomes as a therapeutic intervention to improve urethral sphincter function in patients experiencing post-prostatectomy incontinence (PPI)....
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $2.47 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2029. The project, titled "Allograft vs. Autograft to Improve Timely Return to Duty Following Nonunion," supports advanced biomedical research addressing critical health challenges relevant to...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.48M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with an ultimate completion date of September 29, 2029. The grant supports the Intraosseous Antibiotics for Osseointegration (IOAOI) research initiative, which investigates advanced biomedical solutions for military-relevant trauma interventions. This project...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $770,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 15, 2025, with a completion date of September 14, 2028. The award supports the development of advanced biocompatible cryopreservation techniques for eyelid and periorbital tissues, research to be conducted at the institution's facilities in Winston-Salem, North...
- Federal Project Grant Award Summary The University of Virginia received a $1.7M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded May 1, 2026, with completion scheduled for April 30, 2029. This award supports research focused on preserving lung integrity and harnessing inflammation to treat burn-induced inhalation injury. The research will be conducted at the university's Charlottesville, Virginia campus and is...
- Federal Project Grant Award Summary Award: The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded Duke University's Office of Research Administration a Project Grant of $564,705 on September 15, 2025, for research extending through September 14, 2028. The award supports the identification of oncofusion-interacting proteins as essential drug targets for common and rare oncofusions in rhabdomyosarcoma. This research initiative aligns...
- This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...
Wake Forest University Health Sciences received a $1,143,840 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026, with a completion date of June 30, 2029. The project, titled "Validation of In Vitro and In Vivo Paired Models of Jet Fuel Exposures for Biomarker Identification," will be conducted at the awardee's facility in Winston-Salem, North Carolina. This three-year research initiative focuses on developing and validating laboratory and animal models to assess the health effects of jet fuel exposure, with the primary objective of identifying reliable biomarkers that can indicate physiological responses to such exposures. The research outputs will support DHA's broader mission to transform healthcare for military service members through innovative biomedical solutions addressing occupational health threats. By establishing paired in vitro (laboratory-based cellular) and in vivo (animal model) approaches, this project will generate validated methodologies and biomarker data applicable to assessing and monitoring health risks associated with jet fuel exposure in military personnel. The findings are expected to contribute to evidence-based occupational health protections and medical surveillance protocols for military aviation communities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 5/18/26 |